Traditional clinical risk factors predict clopidogrel hypo-responsiveness in unselected patients undergoing

Hanna Ratcovich1, Lene Holmvang1, Pär Inge Johansson2

  • 1a Department of Cardiology , Copenhagen University Hospital, Rigshospitalet , Copenhagen , Denmark and.

Platelets
|May 1, 2015
PubMed

Insights

The PREDICT score effectively identifies patients at high risk for high platelet reactivity to clopidogrel after PCI. However, it shows a weaker correlation with aspirin response, suggesting targeted platelet function testing for high-risk individuals.

Area of Science:

  • Cardiology
  • Pharmacology
  • Clinical Medicine

Background:

  • High and low platelet reactivity (HPR/LPR) to clopidogrel and aspirin are linked to adverse events post-percutaneous coronary intervention (PCI).
  • Predictive clinical risk scores aim to stratify patient risk for tailored antiplatelet therapy.

Purpose of the Study:

  • To evaluate the PREDICT score's ability to identify patients with HPR and LPR following PCI.
  • To assess the correlation between the PREDICT score and platelet reactivity to clopidogrel and aspirin.

Main Methods:

  • 923 patients undergoing non-emergent PCI were enrolled.
  • Platelet reactivity was measured using Multiplate assays, defining HPR and LPR by upper and lower quintiles.
  • Patients were assigned PREDICT score points based on clinical factors: age, left ventricular function, kidney function, ACS, and diabetes.

Main Results:

  • A significant association was found between higher PREDICT scores and increased risk of HPR to clopidogrel (ADP).
  • The PREDICT score demonstrated an inverse relationship with LPR to clopidogrel (ADP).
  • No clear association was observed between the PREDICT score and HPR to aspirin (AA).

Conclusions:

  • The PREDICT score is valuable for identifying patients at high risk of HPR to clopidogrel, potentially guiding antiplatelet therapy selection.
  • The PREDICT score's utility in predicting aspirin response is limited.
  • Platelet function testing may be reserved for patients with a high clinical likelihood of HPR, as indicated by the PREDICT score.

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...